To this end, iPSCs carrying CRISPR/Cas9-induced alterations of PTEN/NF1 and TP53/PDGFRA, which are commonly observed in mesenchymal and proneural molecular subtypes of glioblastoma [155,156], were differentiated into neural progenitor cells (NPCs). The gene discussed is PTEN; the disease is glioblastoma.